Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New wearable gadget aims to take the ache out of back pain

NCT ID NCT07195422

Symptom relief Sponsor: Japet Medical Devices Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a wearable device called Japet.W+ that supports the lower back. Researchers want to see if wearing it during daily activities reduces pain and helps people move better. About 102 adults with chronic low back pain will either use the device plus standard care or standard care alone. The main goal is pain relief, with secondary goals like improved quality of life and less medication use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Japet.W+ wearable back support device
What this could lead to
If it works, this device could offer a new, drug-free option to ease chronic low back pain and improve daily activities.
What could go wrong
This is a small, early-stage study (102 people) testing a device, not a cure. Results may not apply to everyone, and the device may not reduce pain significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 102 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Non-specific chronic low back pain with active discopathy OR Non-specific chronic low back pain without active discopathy, * 18 years ≤ Age \< 80 years, * Average pain intensity (VAS) over the last week ≥ 40/100, * Patient affiliated to the health social security system, * Patient able to understand the information relating to the study and to sign the informed consent form. Exclusion Criteria: * Specific low back pain (infectious, inflammatory, tumorous, or traumatic in origin). * Motor neurological deficits (peripheral or central). * Extrapyramidal syndrome. * Treatment with implanted neurostimulation. * Severe heart or circulatory disease or respiratory problems. * Arthrodesis or disc replacement. * Surgery for herniated disc (\<3 months). * Spinal fracture or floating ribs (\<3 months). * Skin lesions on the trunk, history of contusions or skin lesions following traction of the trunk. * Pregnancy. * Patients who cannot tolerate the JAPET.W+ device during an initial trial. * Patients under guardianship, curatorship, or legal protection. * Participation in another clinical trial. * Patients who have worn a device designed to reduce lower back pain regularly during the 2 weeks prior to inclusion (lumbar belt, corset, exoskeleton).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Clermont-Ferrand

    RECRUITING

    Clermont-Ferrand, France

  • Hôpital de Cochin, APHP

    RECRUITING

    Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.